chartexchange

PULM
Pulmatrix, Inc. Common Stock
stockNASDAQ

At CloseNov 17, 2026 3:54:50 PM EST
1.39USD+4.511%(+0.06)3,529
Pre-marketNov 17, 2026 8:05:30 AM EST
1.45USD+9.023%(+0.12)
After-hoursNov 17, 2026 4:24:30 PM EST
1.4876USD+7.022%(+0.0976)
1.1300Bid1.6000Ask0.4700Spread
Loading…
Loading…
Healthcare
Biotechnology
HQ
Lexington, MA, USA
Previous Close
$1.33
Beta
0.66
52-Week High
$4.98 2025-11-17
52-Week Low
$1.06 2026-11-04
SMA 50
$1.46
SMA 200
$1.65
Avg. Vol 10D
46,821
Avg. Vol 30D
30,964
Avg. Vol 90D
27,108
Relative Vol
0.09
3.65M
5.2900%
276
Nov 19, 2026 (2d)
Mar 1, 2022 · 1-for-20 (reverse)
PULM Profile

pulmatrix is a clinical stage biotechnology company with an inhaled dry powder platform advancing a new generation of inhaled therapeutics. the platform, called isperse (inhaled small particles easily respirable and emitted), represents a new paradigm in inhaled drug delivery based on unique properties: dense, high drug load engineered particles with highly efficient dispersibility and delivery to the airways. the isperse powders can be used with an array of dry powder inhaler technologies and can be formulated with virtually any drug substance.

PULM Performance
PeriodPriceDateChangeBeta
1W1.352026-11-10+3.70%-1.866
1M1.362026-10-16+2.94%1.592
3M1.562026-08-17-10.26%1.300
6M1.262026-05-18+11.11%0.637
1Y4.752025-11-17-70.53%0.663
2Y6.722024-11-18-79.17%—
5Y15.052021-11-17-90.70%-0.078
PULM Stock Summary

Pulmatrix, Inc. Common Stock (NASDAQ:PULM) stock price today is $1.40, and today's volume is 2,838. PULM is up 5.263% today. The 30 day average volume is 30,964. PULM market cap is $5.11M with 3.65M shares outstanding.